Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Trade Desk Inc (TTD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Trade Desk Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69.4 (market cap $30.93B), while Trade Desk Inc trades at $12.12 (market cap $5.76B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 5.4× Trade Desk Inc's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Trade Desk Inc pays none. Which is the better fit depends on your goals.
| GEHC | TTD | |
|---|---|---|
Market Cap | $30.93B | $5.76B |
Volume | 5,033,451 | 17,724,516 |
Sector | Health | Media |
52-Week High | $88.16 | $54.13 |
52-Week Low | $59.48 | $11.92 |
Enterprise Value | $39.39B | $4.71B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 73 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
The Trade Desk (TTD) trades at $12.17, down 68% year-to-date amid a bearish technical outlook and slowing revenue growth. Recent earnings show mixed results with a Q2 beat but a Q1 miss, while Q3 2026 guidance indicates a 12% revenue decline. The company maintains strong profitability margins and a low P/E ratio, but faces intense competition from tech giants and has announced workforce reductions.
The stock presents a high-risk opportunity with a consensus price target of $14.68 offering potential upside, though near-term headwinds from competition and index removal flows persist. Long-term prospects hinge on the company's ability to defend its open internet ad platform against Amazon and Google while restoring growth momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Trade Desk Inc
The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.
Read more on TTD →
